Congratulations to Dr Nihal Kenawy who completed her MD on conjunctival melanoma earlier this month. Well deserved!
Professor Sarah Coupland participated in the 9th Chinese Congress of Research in Vision and Ophthalmology in Beijing earlier this month.
The programme included:
1）Ocular microbiome, immunology, infections
2）Neurobiology, blindness due to optic nerve diseases
3）Genetics, ophthalmic genetic diseases
4）Cell and molecular biology, stem cell and gene therapies
5）Bioengineering, optic and optical related diseases
6）Vision science, vision development and related diseases
7）Translational research in ophthalmology and vision science
8）Vascular development and formation
Congratulations to Prof Sarah Coupland who attended Birkenhead Town Hall on Thursday 9th February 2017 to attain British Citizenship. The ceremony was conducted by the registrar and Mayor of Wirral, Councillor Pet Hackett.
Prof. Coupland Vice Chair of the 8 Eye Cancer Chapters in the recently completed 8TH EDITION AJCC-TNM CANCER STAGING
The American Joint Committee on Cancer (AJCC) recently celebrated the completion of the 8th edition of its Cancer Staging Manual.
The AJCC Cancer Staging Manual defines an international language for oncology. Created with and adopted by the Union for International Cancer Control (UICC), the AJCC-UICC TNM Cancer Classifications enables communication between cancer care providers all over the world. The manual brings together all currently available information on staging of cancer, and incorporates newly acquired knowledge on cancer aetiology and pathology.
The AJCC Cancer Staging Manual:
New Edition of ESMO/ASCO Global Curriculum in Medical Oncology – Setting Standards for Modern Training
The leading European professional organisation for medical oncology (the European Society of Medical Oncology, ESMO), in collaboration with the American Society of Clinical Oncology (ASCO), published the 2016 edition of the ESMO/ASCO Recommendations for a Global Curriculum (GC) in Medical Oncology, a set of common guidelines to offer a global perspective of the clinical training required for physicians to qualify as medical oncologists. ESMO used its recent and well-attended conference in October in Copenhagen Denmark in October, to announce the release of its Curriculum.
Professor Sarah Coupland, who was part of the GC writing group as a cancer- and molecular pathologist, added: “ This is a unique work, put together by experts involved in cancer patient care and cancer diagnostics. By drawing up recommendations for training in this field, we are aiming for high quality and consistency in cancer teaching across the globe, and thereby help address inequalities and future proofing in cancer patient care".
The integration of molecular pathology to determine the presence of biomarkers as criteria to select appropriate new therapies is one of the most appreciable novelties now included in the 2016 edition of the GC, making it a fundamental reference for internationally recognised standards for medical oncology training.
Professor Sarah Coupland added: “Molecular pathology is essential for understanding cancer development, and is becoming integral for all cancer diagnostics, prognostication, as well as treatment response prediction and monitoring". She adds that this feeds very well into various initiatives underway in the UK, including the NCRI CM-Path programme (www.ncri.org.uk/initiatives/pathology/), in which Prof. Coupland is also involved.
The Liverpool Ocular Oncology Research Group are pictured here at the North West Cancer Research Centre-University of Liverpool showing solidarity and displaying science knows no cultural boundaries.
Congratulations to Natalie Kipling pictured here with Prof Sarah Coupland (left) and Dr Helen Kalirai (right) for achieving a very high mark of 88% in her undergraduate final year project 'Immunohistochemical characterisation of uveal melanoma cells grown as 3D spheroids'. Natalie is completing an undergraduate degree in Biomedical Science at Liverpool John Moores University and did her final year project with Prof Coupland and Dr Kalirai in LOORG with help from the Immunohistochemistry team and Histopathology department at the Royal Liverpool Hospital. Well done Natalie!
The Association for Research in Vision and Ophthalmology (ARVO) has elected Professor Sarah Coupland as their new Vice-President Elect for 2017-2018.
ARVO is the largest eye and vision research organisation in the world. It has helped to advance research into understanding the visual system and preventing, treating and curing its disorders. Over 12,000 researchers from 75 countries are members and attend the annual meeting in May each year.
Prof Coupland, said: “I am honoured to have been elected to this prestigious position, and I am looking forward to playing such a significant role in promoting its members and the field of ophthalmology and vision research.”
The announcement was made at the ARVO 2016 Annual Meeting in Seattle, and marks the first time a non-US female has been elected to the role. Congratulations to Sarah!
Prof Coupland had a jam-packed schedule at this years Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Seattle. Sarah is on the Board of Trustees, which includes attending many meetings in addition to her presenting her work. ARVO attracts around 12,000 delegates each year.
Prof Sarah Coupland is pictured here with Dr Nicolas Bazan (Director and Founder of Neuroscience Center of Excellence, LSUHSC, School of Medicine, New Orleans, LA) and Dr Geeta Vemuganti (Dean of Medical Sciences, Hyderabad, India), at the beginning of the ARVO WEAVR lunch, which had 350 attendees. Geeta gave a very inspirational talk to the audience, whilst Sarah moderated the session which lasted 1.5 hours!
Sarah is pictured here with Iris Rush, Dr Geeta Vemuganti and Emily Chew.
Want to know more?
You can now follow LOORG on Twitter to find out what we’re up to, and the current issues in research. Click here for further information.